![Anne-Marie Carbonell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne-Marie Carbonell active positions
Companies | Position | Start | End |
---|---|---|---|
OncoSynergy, Inc.
![]() OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT. | Chief Executive Officer | 01/08/2019 | - |
Chief Tech/Sci/R&D Officer | 01/08/2019 | - | |
Founder | 01/01/2011 | - |
Career history of Anne-Marie Carbonell
Statistics
International
United States | 2 |
Operational
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
OncoSynergy, Inc.
![]() OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT. | Health Technology |
- Stock Market
- Insiders
- Anne-Marie Carbonell
- Experience